Related references
Note: Only part of the references are listed.Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
Liwen Wang et al.
GUT (2023)
Development of PI3Kα inhibitors for tumor therapy
Wenqing Jia et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma
C. Robert et al.
ANNALS OF ONCOLOGY (2022)
Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer
Leila Kooshki et al.
BIOFACTORS (2022)
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma
Qing Xia et al.
ONCOGENE (2022)
A Valve-Closing Starvation Strategy for Amplification of Tumor-Specific Chemotherapy
Xianglong Li et al.
ADVANCED SCIENCE (2022)
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
Gabriela Reyes-Castellanos et al.
CELLS (2022)
PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-κB Signaling Pathway in Ovarian Cancer
Yu-xin Jiang et al.
FRONTIERS IN ONCOLOGY (2022)
2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation
Xiaodong Sun et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Oxamate targeting aggressive cancers with special emphasis to brain tumors
Meric A. Altinoz et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma
Richard A. Noble et al.
BRITISH JOURNAL OF CANCER (2022)
Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux
Brandon C. Jones et al.
CANCER AND METASTASIS REVIEWS (2022)
Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Qianying Zuo et al.
MOLECULAR CANCER RESEARCH (2022)
The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways
Hao-Cheng Weng et al.
FRONTIERS IN PHARMACOLOGY (2022)
Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy
Marta Mascaraque-Checa et al.
MOLECULAR METABOLISM (2022)
Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer
Jia Bo Zheng et al.
ONCOIMMUNOLOGY (2022)
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Yang Liu et al.
ONCOIMMUNOLOGY (2022)
ENO1 and Cancer
Chen Kai Huang et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion
Byong-Sop Song et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment
Yunlong Shan et al.
ACTA PHARMACEUTICA SINICA B (2022)
A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
Elaine Chow et al.
PHARMACEUTICALS (2022)
Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy
Jun Lei et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity
Luyan Shen et al.
CANCER LETTERS (2022)
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Samaneh Mostafavi et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)
The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2022)
A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer
Mao-Lin Chen et al.
MOLECULAR CANCER THERAPEUTICS (2022)
A Nanounit Strategy Disrupts Energy Metabolism and Alleviates Immunosuppression for Cancer Therapy
Yang Luo et al.
NANO LETTERS (2022)
?Warburg effect? controls tumor growth, bacterial, viral infections and immunity-Genetic deconstruction and therapeutic perspectives
J. Pouyssegur et al.
SEMINARS IN CANCER BIOLOGY (2022)
3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells
Jiachen Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2022)
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
Shijun Ma et al.
NATURE COMMUNICATIONS (2022)
Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8+ T Cells for Enhanced IFNγ Production by Metformin
Ruoyu Chao et al.
FRONTIERS IN IMMUNOLOGY (2022)
HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)
Chang W. Song et al.
CANCERS (2022)
Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells
B. Rhodes Ford et al.
SCIENCE IMMUNOLOGY (2022)
The combination of hydroxychloroquine and 2-deoxyglucose enhances apoptosis in breast cancer cells by blocking protective autophagy and sustaining endoplasmic reticulum stress
Ning Zhou et al.
CELL DEATH DISCOVERY (2022)
Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I?Ba
Dong Guo et al.
CELL METABOLISM (2022)
The multiple roles of LDH in cancer
Giuseppina Claps et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Recent advances in CAR-T cells therapy for colorectal cancer
Xiaoling Qin et al.
FRONTIERS IN IMMUNOLOGY (2022)
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Jiawen Huang et al.
FRONTIERS IN IMMUNOLOGY (2022)
5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action
Mantas Grigalavicius et al.
CANCERS (2022)
Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
Yi Zhang et al.
CANCERS (2022)
FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
Guanghui Zhong et al.
JOURNAL OF ONCOLOGY (2022)
Relationship between metabolic reprogramming and drug resistance in breast cancer
Linlin Lv et al.
FRONTIERS IN ONCOLOGY (2022)
Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patients
Enas M. Omar et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2022)
Clinical development of metabolic inhibitors for oncology
Kathryn M. Lemberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology
S. J. Kierans et al.
JOURNAL OF PHYSIOLOGY-LONDON (2021)
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma
Liangyuan Chen et al.
EXPERIMENTAL CELL RESEARCH (2021)
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E. Scharping et al.
NATURE IMMUNOLOGY (2021)
Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
Ke Xu et al.
SCIENCE (2021)
Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4+ Treg cells in ovarian cancer cells microenvironment
Rui Xu et al.
CELL DEATH & DISEASE (2021)
Pharmacological activation of pyruvate kinase M2 reprograms glycolysis leading to TXNIP depletion and AMPK activation in breast cancer cells
Fadi Almouhanna et al.
CANCER & METABOLISM (2021)
Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
Yongbo Yu et al.
CELL DEATH DISCOVERY (2021)
Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells
Pritpal Kaur et al.
PLOS ONE (2021)
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
McLane J. Watson et al.
NATURE (2021)
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients
Liu Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Altered glycolysis results in drug-resistant in clinical tumor therapy
Jinghui Peng et al.
ONCOLOGY LETTERS (2021)
Glycolysis-induced drug resistance in tumors-A response to danger signals?
Fabrizio Marcucci et al.
NEOPLASIA (2021)
Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target
Frankis A. Almaguel et al.
FRONTIERS IN GENETICS (2021)
Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
Wenhua Xu et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells
Ernestina Saulle et al.
FRONTIERS IN ONCOLOGY (2021)
Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+T cells via pharmacological activation of FOXO3
Young Min Chung et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy
Marco Fiorillo et al.
FRONTIERS IN ONCOLOGY (2021)
3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
Irini Skaripa-Koukelli et al.
CANCER & METABOLISM (2021)
Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH
Kyoung Song et al.
PHARMACEUTICALS (2021)
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
Claudia Curcio et al.
MOLECULES (2021)
The complex Integration of T-cell Metabolism and Immunotherapy
Matthew Z. Madden et al.
CANCER DISCOVERY (2021)
The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition
Besa Emini Veseli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Phase I expansion study of the first-in-class monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL).
Sarah E. R. Halford et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes
Christina P. Martins et al.
FRONTIERS IN IMMUNOLOGY (2021)
Defueling the cancer: ATP synthase as an emerging target in cancer therapy
Ting Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Glucose Transporters as a Target for Anticancer Therapy
Monika Pliszka et al.
CANCERS (2021)
PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells
Iga Jancewicz et al.
CANCERS (2021)
Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
Friederike Steifensand et al.
CELLS (2021)
Glucose Metabolism and Glucose Transporters in Breast Cancer
Eunah Shin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin
Shaomeng Chen et al.
BIOMOLECULES (2021)
Metabolic barriers to cancer immunotherapy
Kristin DePeaux et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Photodynamic Therapy for Cancer: What's Past is Prologue
Michael R. Hamblin
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2020)
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker et al.
CANCER CELL (2020)
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
Sonia Guedan et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
Shamir Cassim et al.
CANCERS (2020)
Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer
Shan Shao et al.
FASEB JOURNAL (2020)
GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers
Jun Wang et al.
CANCER LETTERS (2020)
Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy
Lin Wu et al.
CELL (2020)
Mitochondrial Metabolism as a Target for Cancer Therapy
Karthik Vasan et al.
CELL METABOLISM (2020)
A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressingHER2expression in breast cancer
Panhong Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
Maria Sfakianaki et al.
CANCERS (2020)
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC
Derek A. Franklin et al.
JCI INSIGHT (2020)
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
Kalpana Tilekar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Association of TIM-3 expression with glucose metabolism in Jurkat T cells
Mi Jin Lee et al.
BMC IMMUNOLOGY (2020)
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Jackie E. Bader et al.
MOLECULAR CELL (2020)
Disturbed mitochondrial dynamics in CD8+TILs reinforce T cell exhaustion
Yi-Ru Yu et al.
NATURE IMMUNOLOGY (2020)
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Qin Wu et al.
NATURE COMMUNICATIONS (2020)
Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer
Xuguang Yang et al.
CANCER IMMUNOLOGY RESEARCH (2020)
MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes
Vipin Shankar Chelakkot et al.
SCIENTIFIC REPORTS (2020)
Extracellular ATP: A Feasible Target for Cancer Therapy
Valentina Vultaggio-Poma et al.
CELLS (2020)
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michael Cerezo et al.
CELL DEATH & DISEASE (2020)
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination
Giorgia Mandili et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Yu-Hsi Lin et al.
NATURE METABOLISM (2020)
Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells
Huizhen Sun et al.
THERANOSTICS (2020)
Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy
Ramon I. Klein Geltink et al.
NATURE METABOLISM (2020)
Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI
Junfeng Zhang et al.
THERANOSTICS (2020)
Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy
Lei Gan et al.
ONCOTARGETS AND THERAPY (2020)
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
Susmita Mondal et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
Hiroshi Sawayama et al.
CANCER SCIENCE (2019)
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
Tengjiao Fan et al.
CANCERS (2019)
Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma
Dong-Ping Chen et al.
JOURNAL OF HEPATOLOGY (2019)
Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4+ T Cells
Dana M. Previte et al.
CELL REPORTS (2019)
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Jie Deng et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
Othman Al-Sawaf et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Phenformin as an Anticancer Agent: Challenges and Prospects
Ma Eugenia Garcia Rubino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E. W. Cohen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
Yogesh Rai et al.
BIOSCIENCE REPORTS (2019)
In order for the light to shine so brightly, the darkness must be present-why do cancers fluoresce with 5-aminolaevulinic acid?
Kym McNicholas et al.
BRITISH JOURNAL OF CANCER (2019)
The progress and development of GLUT1 inhibitors targeting cancer energy metabolism
Ying Meng et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments
Yoojung Kwon et al.
CANCERS (2019)
PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells
Siyuan Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells
Yu-Liang Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer
Yutaro Mori et al.
STEM CELL REPORTS (2019)
A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer
Ke Huang et al.
CELL METABOLISM (2019)
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
Eylem Kulkoyluoglu-Cotul et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin
A. Flores et al.
NATURE COMMUNICATIONS (2019)
Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells
Lelisa F. Gemta et al.
SCIENCE IMMUNOLOGY (2019)
Metabolic Dysregulation Controls Endocrine Therapy-Resistant Cancer Recurrence and Metastasis
Malachi A. Blundon et al.
ENDOCRINOLOGY (2019)
The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Pedro Gonzalez-Menendez et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer
Fatima Pashaei-Asl et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou et al.
BMC CANCER (2018)
Glucose Metabolism in Cancer: The Saga of Pyruvate Kinase Continues
Annamarie E. Allen et al.
CANCER CELL (2018)
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Romana T. Netea-Maier et al.
CANCER LETTERS (2018)
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Tina Cascone et al.
CELL METABOLISM (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
The Science and Translation of Lactate Shuttle Theory
George A. Brooks
CELL METABOLISM (2018)
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
Ming-Chuan Hsu et al.
MOLECULAR CANCER (2018)
A novel alpha-enolase-targeted drug delivery system for high efficacy prostate cancer therapy
Luyao Wang et al.
NANOSCALE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth
Ilenia Pacella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
mTOR coordinates transcriptional programs and mitochondrial metabolism of activated T-reg subsets to protect tissue homeostasis
Nicole M. Chapman et al.
NATURE COMMUNICATIONS (2018)
Exosome-mediated breast cancer chemoresistance via miR-155 transfer
Juliana Carvalho Santos et al.
SCIENTIFIC REPORTS (2018)
Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway
Ema Yoshioka et al.
THERANOSTICS (2018)
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress
Pedro Gonzalez-Menendez et al.
REDOX BIOLOGY (2018)
Targeting glycolysis enzyme, PFKFB3, in endocrine therapy resistant breast cancers
Surojeet Sengupta et al.
CANCER RESEARCH (2018)
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the Warburg effect restricting tumor growth to oxidative metabolism
Masa Zdralevic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells
Zeiyad Alkarakooly et al.
PLOS ONE (2018)
GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
Simran S. Sabharwal et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
Zahra Nozhat et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy
Marco Fiorillo et al.
AGING-US (2018)
Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair
Steven T. Sizemore et al.
CELL RESEARCH (2018)
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Toszka Bohn et al.
NATURE IMMUNOLOGY (2018)
Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors
Yang Gao et al.
CELL CHEMICAL BIOLOGY (2018)
Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis
Haiyan Zhu et al.
ONCOTARGET (2017)
Alpha-Enolase (ENO1), a potential target in novel immunotherapies
Paola Cappello et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2017)
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis
Moitza Principe et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer
Panpan Zhan et al.
MOLECULAR CARCINOGENESIS (2017)
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip et al.
NATURE (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
L. Jin et al.
ONCOGENE (2017)
THE COMBINATION OF GLYCOLYTIC INHIBITOR 2-DEOXYGLUCOSE AND MICROBUBBLES INCREASES THE EFFECT OF 5-AMINOLEVULINIC ACID-SONODYNAMIC THERAPY IN LIVER CANCER CELLS
Rui Xie et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2017)
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways
Thuc M. Le et al.
NATURE COMMUNICATIONS (2017)
Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells
Maria Rosaria Ambrosio et al.
ONCOTARGET (2017)
Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
Xiaoling Qian et al.
ONCOTARGET (2017)
The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
Min Yu et al.
ONCOTARGET (2017)
Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
Eva M. Palsson-McDermott et al.
FRONTIERS IN IMMUNOLOGY (2017)
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher A. Klebanoff et al.
JCI INSIGHT (2017)
Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin
Qing Chen et al.
ANTI-CANCER DRUGS (2017)
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Gabriela Andrejeva et al.
CELL METABOLISM (2017)
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J. Kishton et al.
CELL METABOLISM (2017)
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J. Siska et al.
JCI INSIGHT (2017)
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Alessia Angelin et al.
CELL METABOLISM (2017)
A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours.
Sarah E. R. Halford et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Therapeutic strategies targeting cancer stem cells
Go J. Yoshida et al.
CANCER SCIENCE (2016)
Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis
Naomi Tsurutani et al.
JOURNAL OF IMMUNOLOGY (2016)
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence
Elena V. Efimova et al.
MOLECULAR CANCER RESEARCH (2016)
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest
Michela Capello et al.
ONCOTARGET (2016)
Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway
Chong Geng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
Young Chan Chae et al.
CANCER CELL (2016)
Glycoholics Anonymous: Cancer Sobers Up with mTORC1
Vivian Fu et al.
CANCER CELL (2016)
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
Raju V. Pusapati et al.
CANCER CELL (2016)
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
Anna Rita Cantelmo et al.
CANCER CELL (2016)
Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation
Fei Zhao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
Marina Bacci et al.
CANCER RESEARCH (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar et al.
IMMUNITY (2016)
mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
Hu Zeng et al.
IMMUNITY (2016)
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping et al.
IMMUNITY (2016)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Hope S. Rugo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia
Peter J. Siska et al.
JOURNAL OF IMMUNOLOGY (2016)
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
Ninel Azoitei et al.
MOLECULAR CANCER (2016)
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
Aaron Boudreau et al.
NATURE CHEMICAL BIOLOGY (2016)
Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression
Valerie A. Gerriets et al.
NATURE IMMUNOLOGY (2016)
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study
Hakim Mahammedi et al.
ONCOLOGY (2016)
Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
Goran Hamid Mohammad et al.
PLOS ONE (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro
Sujuan Yuan et al.
YONSEI MEDICAL JOURNAL (2016)
Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
Jiayuan Wu et al.
ONCOTARGETS AND THERAPY (2016)
Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response
Xue Yang et al.
ONCOTARGET (2016)
PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
Haiyan Zhu et al.
SCIENTIFIC REPORTS (2016)
Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats
Takeshi Hara et al.
FEBS OPEN BIO (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
Wei Zhu et al.
PLOS ONE (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies
Fausto Petrelli et al.
ACTA ONCOLOGICA (2015)
Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines
Yasmin M. Attia et al.
BMC CANCER (2015)
Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo
Mao-Bin Meng et al.
CANCER LETTERS (2015)
Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: Involvement of the Akt-mTOR signaling pathway
Zhi Zhao et al.
CANCER LETTERS (2015)
Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin In Vivo and In Vitro
Qi Zhang et al.
CANCER PREVENTION RESEARCH (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Beth Kelly et al.
CELL RESEARCH (2015)
Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
Eleni Efstathiou et al.
EUROPEAN UROLOGY (2015)
A phase I, dose-escalation, multicenter study of ACT-PFK-158, 2HCl in patients with advanced solid malignancies explores a first-in-human inhibitor of glycolysis
Rebecca Ann Redman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway
Qiao-Fen Fu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
Nelma Pertega-Gomes et al.
JOURNAL OF PATHOLOGY (2015)
Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling
Fahim Atif et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells
Zhike Chen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
Tian-Lin He et al.
MEDICAL ONCOLOGY (2015)
Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications
Rebecca Kohnken et al.
MOLECULAR CANCER (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
Anti-α-enolase is a prognostic marker in postoperative lung cancer patients
Kuan-Chung Hsiao et al.
ONCOTARGET (2015)
Targeting lactate transport suppresses in vivo breast tumour growth
Filipa Morais-Santos et al.
ONCOTARGET (2015)
High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
Yang Lin et al.
JOURNAL OF CANCER (2015)
Dietary Iron Controls Circadian Hepatic Glucose Metabolism Through Heme Synthesis
Judith A. Simcox et al.
DIABETES (2015)
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
Valerie A. Gerriets et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma
Robert T. Wicks et al.
NEURO-ONCOLOGY (2015)
Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
Yu Mi Woo et al.
PLOS ONE (2015)
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells
Keita Shibuya et al.
ONCOTARGET (2015)
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer
C. Papadaki et al.
BRITISH JOURNAL OF CANCER (2014)
Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
Han Xie et al.
CELL METABOLISM (2014)
Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
Sandra Schoors et al.
CELL METABOLISM (2014)
Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells
Yuanyuan Cui et al.
ENDOCRINE-RELATED CANCER (2014)
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
Ye Song et al.
MOLECULAR CANCER (2014)
Type 2 diabetic conditions in Otsuka Long-Evans Tokushima Fatty rats are ameliorated by 5-aminolevulinic acid
Takashi Sato et al.
NUTRITION RESEARCH (2014)
Synergistic Anti-Cancer Effect of Phenformin and Oxamate
W. Keith Miskimins et al.
PLOS ONE (2014)
Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death
Xiaolan Feng et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2014)
Dual inhibition of autophagy and the AKT pathway in prostate cancer
Francois Lamoureux et al.
AUTOPHAGY (2013)
Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy
J. P. Golding et al.
BRITISH JOURNAL OF CANCER (2013)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Hexokinase II in breast carcinoma: A potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67
Akiko Sato-Tadano et al.
CANCER SCIENCE (2013)
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Katrien De Bock et al.
CELL (2013)
Role of Endothelial Cell Metabolism in Vessel Sprouting
Katrien De Bock et al.
CELL METABOLISM (2013)
Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer
Paola Cappello et al.
GASTROENTEROLOGY (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Oncometabolites: linking altered metabolism with cancer
Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Lactate Dehydrogenase 5 Expression in Non-Hodgkin Lymphoma Is Associated with the Induced Hypoxia Regulated Protein and Poor Prognosis
Renquan Lu et al.
PLOS ONE (2013)
Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer
Yuichiro Hagiya et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
Arianna Calcinotto et al.
CANCER RESEARCH (2012)
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation
Anna N. Mendler et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Weiwei Yang et al.
NATURE CELL BIOLOGY (2012)
Mitochondrial Localization of ABC Transporter ABCG2 and Its Function in 5-Aminolevulinic Acid-Mediated Protoporphyrin IX Accumulation
Hirotsugu Kobuchi et al.
PLOS ONE (2012)
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa
Eric T. Clambey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma
Shanmugasundaram Ganapathy-Kanniappan et al.
ONCOTARGET (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Yuhua Zhao et al.
CANCER RESEARCH (2011)
Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis
Xiaojun Zha et al.
CANCER RESEARCH (2011)
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker
Katia C. Carvalho et al.
CLINICS (2011)
Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model
Wenhao Guo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
Lewis Z. Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism
Nancie J. MacIver et al.
JOURNAL OF IMMUNOLOGY (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
Ayako Nakano et al.
PLOS ONE (2011)
Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth
Qian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
Dimitrios Anastasiou et al.
SCIENCE (2011)
Glyoxalase in tumourigenesis and multidrug resistance
Paul J. Thornalley et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells
Shih-Hsin Tu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice
Hua-shan Shi et al.
CANCER SCIENCE (2010)
3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
S. Ganapathy-Kanniappan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction
Sen-Tien Tsai et al.
EUROPEAN JOURNAL OF CANCER (2010)
The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin
Rajesh R. Rao et al.
IMMUNITY (2010)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats
Chong-Ki Lee et al.
PHARMACOLOGY (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
Paola Cappello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Evaluation of the Role of Hexokinase Type II in Cellular Proliferation and Apoptosis Using Human Hepatocellular Carcinoma Cell Lines
Keun Jae Ahn et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Glucose uptake is limiting in T cell activation and requires CD28-mediated akt-dependent and independent pathways
Sarah R. Jacobs et al.
JOURNAL OF IMMUNOLOGY (2008)
Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway
Hiroaki Shime et al.
JOURNAL OF IMMUNOLOGY (2008)
Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II
S. Miyamoto et al.
CELL DEATH AND DIFFERENTIATION (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+T regulatory cells
Heather Kopf et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Proteomics-based identification of α-enolase as a tumor antigen in non-small lung cancer
Ping He et al.
CANCER SCIENCE (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Non-[F-18]FDG PET in clinical oncology
Ashley M. Groves et al.
LANCET ONCOLOGY (2007)
Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis
Gillian K. Reeves et al.
LANCET ONCOLOGY (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1α
C Handschin et al.
CELL (2005)
Differential effects of glucose deprivation on the cellular sensitivity towards photodynamic treatment-based production of reactive oxygen species and apoptosis-induction
T Kiesslich et al.
FEBS LETTERS (2005)
Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines
BC Yoo et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer
D Rivenzon-Segal et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Scavengers protection of cells against ALA-based photodynamic therapy-induced damage
C Perotti et al.
LASERS IN MEDICAL SCIENCE (2002)
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
K Gottlob et al.
GENES & DEVELOPMENT (2001)
Share Paper
